Literature DB >> 8681602

Study of critically ill patients with systemic lupus erythematosus.

S M Ansell1, S Bedhesi, B Ruff, A G Mahomed, G Richards, M Mer, C Feldman.   

Abstract

OBJECTIVES: To determine the presenting features, prognostic factors, course, and outcome of critically ill patients with systemic lupus erythematosus admitted to the intensive care unit (ICU).
DESIGN: Retrospective patient record review.
SETTING: Two academic teaching hospitals. PATIENTS: All patients with systemic lupus erythematosus admitted to the ICUs between January 1982 and July 1993.
MEASUREMENTS AND MAIN RESULTS: There were 28 female and two male patients. Fifteen patients were white, 11 patients were black, and four patients were Asian. The median age was 29 yrs. The reasons for admission to the ICU were multifactorial. However, most patients were admitted for infective, renal, cardiac, or coagulation complications. Despite aggressive management, 16 (53%) patients died in the ICU or shortly after discharge. The median ICU survival rate (admission to death) was 22 days. The only pretreatment factor that predicted a poor outcome was the presence of renal involvement due to systemic lupus erythematosus.
CONCLUSIONS: Our study suggests that patients with systemic lupus erythematosus admitted to an ICU often have florid disease manifestations with multifactorial reasons precipitating the admission. The prognosis for such patients is poor, particularly in the presence of renal involvement.

Entities:  

Mesh:

Year:  1996        PMID: 8681602     DOI: 10.1097/00003246-199606000-00018

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  Outcome of patients with connective tissue disease requiring intensive care for respiratory failure.

Authors:  Jinwoo Lee; Jae-Joon Yim; Seok-Chul Yang; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Eun Young Lee; Eun Bong Lee; Yeong Wook Song; Sang-Min Lee
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

2.  Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit.

Authors:  Alimohammad Fatemi; Somayeh Shamsaee; Ahmad Raeisi; Zahra Sayedbonakdar; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2017-09-06       Impact factor: 2.980

3.  Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  F M K Williams; S Chinn; G R V Hughes; R M Leach
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

4.  Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit.

Authors:  Mickaël Moreels; Christian Mélot; Marc Leeman
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

5.  Survival of patients with SLE admitted to an intensive care unit-a retrospective study.

Authors:  D A Whitelaw; R Gopal; V Freeman
Journal:  Clin Rheumatol       Date:  2004-11-25       Impact factor: 2.980

6.  [Outcome of intensive medical care for inflammatory rheumatic diseases].

Authors:  L A Rütter; S Rütter; M Winkler; G Keyßer
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

7.  Renal cortical necrosis at presentation in a patient with systemic lupus erythematosus: an autopsy case report.

Authors:  Megha S Uppin; Liza Rajasekhar; H Swetha; V R Srinivasan; Aruna K Prayaga
Journal:  Clin Rheumatol       Date:  2010-02-19       Impact factor: 2.980

8.  A nonsense mutation in S-antigen (p.Glu306*) causes Oguchi disease.

Authors:  Nadia K Waheed; Ahmed H Qavi; Sarah N Malik; Maleeha Maria; Moeen Riaz; Frans P M Cremers; Maleeha Azam; Raheel Qamar
Journal:  Mol Vis       Date:  2012-05-12       Impact factor: 2.367

9.  Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study.

Authors:  Chia-Lin Hsu; Kuan-Yu Chen; Pu-Sheng Yeh; Yeong-Long Hsu; Hou-Tai Chang; Wen-Yi Shau; Chia-Li Yu; Pan-Chyr Yang
Journal:  Crit Care       Date:  2005-02-25       Impact factor: 9.097

10.  Acceleration of autoimmunity by organochlorine pesticides in (NZB x NZW)F1 mice.

Authors:  Eric S Sobel; John Gianini; Edward J Butfiloski; Byron P Croker; Joel Schiffenbauer; Stephen M Roberts
Journal:  Environ Health Perspect       Date:  2005-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.